Evidence map›Paper›PMID 41949206›Full record

ArticleStatistics in medicine2026

Powering RCTs for Marginal Effects With GLMs Using Prognostic Score Adjustment.

Emilie Højbjerre-Frandsen, Mark J van der Laan, Alejandro Schuler

Abstract read
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. COADVISE: covariate adjustment with variable selection in randomized controlled trials.Journal of the Royal Statistical Society. Series A, (Statistics in Society) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emilie Højbjerre-FrandsenBiostatistics Methods, Novo Nordisk A/S, Søborg, Denmark.ORCID https://orcid.org/0009-0008-0996-4363
Mark J van der LaanDivision of Biostatistics, University of California Berkeley, Berkeley, California, USA.
Alejandro SchulerDivision of Biostatistics, University of California Berkeley, Berkeley, California, USA.

Funding

Innovationsfonden 2052-00044B
6 · The paper itself

Abstract

In randomized clinical trials (RCTs), the accurate estimation of marginal treatment effects is crucial for determining the efficacy of interventions. Enhancing the statistical power of these analyses is a key objective for statisticians. The increasing availability of historical data from registries, prior trials, and health records presents an opportunity to improve trial efficiency. However, many methods for historical borrowing compromise strict type I error rate control. Building on the work by Schuler et al. on prognostic score adjustment for linear models, this paper extends the methodology to the plug-in analysis proposed by Rosenblum and van der Laan using generalized linear models (GLMs) to further enhance the efficiency of RCT analyses without introducing bias. Specifically, we train a prognostic model on historical control data and incorporate the resulting prognostic scores as covariates in the plug-in GLM analysis of the trial data. This approach leverages the predictive power of historical data to improve the precision of marginal treatment effect estimates. We demonstrate that this method achieves local semi-parametric efficiency under the assumption of an additive treatment effect on the link scale. We expand the GLM plug-in method to include Negative Binomial regression. Additionally, we provide a straightforward formula for conservatively estimating the asymptotic variance, facilitating power calculations that reflect these efficiency gains. Our simulation study supports the theory. Even without an additive treatment effect, we observe increased power or reduced standard error. While population shifts from historical to trial data may dilute benefits, they do not introduce bias. We demonstrate reductions in the estimated variance through an analysis of clinical trial data provided by Novo Nordisk A/S.

Indexed as

Data Interpretation, StatisticalLinear ModelsOutcome Assessment, Health CareRandomized Controlled Trials as TopicBiasComputer SimulationHumansPrognosisRegression Analysiscausal inferencegeneralized linear modelshistorical dataprognostic scorerandomized trialsstatistical efficiency

Identifiers

PMID41949206
PMCPMC13059648

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.